Laser interstitial thermal therapy followed by consolidation stereotactic radiosurgery (LITT-cSRS) in patients with newly diagnosed brain metastasis
10.1007/s11060-024-04712-4 · doi-reference
Hybrid therapy for newly diagnosed and recurrent glioblastoma: staged procedure integrating open surgical resection with laser interstitial thermal therapy
10.1227/ons.0000000000001668 · doi-reference
Intracerebral laser interstitial thermal therapy followed by tumor resection to minimize cerebral edema
10.3171/2016.7.focus16224 · doi-reference
Neoadjuvant PD1 blockade with laser interstitial thermal therapy for recurrent high-grade glioma
10.1016/j.jocn.2025.111823 · doi-reference
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a phase 1/randomized phase 2b trial
10.1038/s41467-026-69522-w · doi-reference
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
10.1186/s13045-024-01544-7 · doi-reference
Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for patients with recurrent glioblastoma
10.1158/1078-0432.ccr-20-2500 · doi-reference
Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma
10.1001/jamaoncol.2020.1024 · doi-reference
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
10.1093/neuonc/noac116 · doi-reference
Laser interstitial thermal therapy induces robust local immune response for newly diagnosed glioblastoma with long-term survival and disease control
10.1097/cji.0000000000000485 · doi-reference
A comprehensive single-cell analysis reveals the impact of laser interstitial thermal therapy on the tumor microenvironment in glioblastoma
10.1093/jimmun/vkaf327 · doi-reference
Laser ablation: heating up the anti-tumor response in the intracranial compartment
10.1016/j.addr.2022.114311 · doi-reference
Synergistic Treatment with Antiretrovirals and Laser Interstitial Thermal ThErapy (STARLITE) for unresectable glioblastoma: a phase 1 study protocol
10.1371/journal.pone.0328204 · doi-reference
The future of clinical trials in surgical neuro-oncology is bright
10.3390/brainsci15121274 · doi-reference
Antiretroviral drug repositioning for glioblastoma
10.3390/cancers16091754 · doi-reference
Antitumour effects of antiretroviral therapy
10.1038/nrc1479 · doi-reference
Effects of HIV protease inhibitor ritonavir on akt-regulated cell proliferation in breast cancer
10.1158/1078-0432.ccr-05-1167 · doi-reference
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
10.1084/jem.20211631 · doi-reference
Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo
10.1158/1535-7163.129.3.2 · doi-reference
MR-guided laser interstitial thermal therapy followed by early application of temozolomide for recurrent IDH-wildtype glioblastomas: preliminary results from a prospective study
10.1007/s10143-025-03402-7 · doi-reference
Hyperthermic laser ablation of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain barrier
10.1371/journal.pone.0148613 · doi-reference
Prolonged blood-brain barrier disruption following laser interstitial ablation in epilepsy: a case series with a case report of postablation optic neuritis
10.1016/j.wneu.2017.05.009 · doi-reference
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
10.1038/s41568-019-0205-x · doi-reference
Single-institution comparative study of magnetic resonance–guided laser interstitial thermal therapy and open corpus callosotomy
10.1016/j.wneu.2023.03.082 · doi-reference
Laser ablation for corpus callosotomy: systematic review and pooled analysis
10.1016/j.seizure.2022.02.002 · doi-reference
MRI-guided stereotactic laser corpus callosotomy for epilepsy: distinct methods and outcomes
10.3171/2020.7.jns20498 · doi-reference
A comparison between magnetic resonance-guided laser interstitial thermal therapy and resective surgery for drug-resistant epilepsy in patients with MRI-positive focal cortical dysplasia: a systematic review and meta-analysis
10.1016/j.eplepsyres.2025.107660 · doi-reference
MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy
10.1111/epi.13106 · doi-reference
Focal cortical dysplasia and refractory epilepsy: role of multimodality imaging and outcome of surgery
10.3174/ajnr.a6041 · doi-reference
Surgical treatment of hypothalamic hamartomas
10.1007/s10143-020-01298-z · doi-reference
Magnetic resonance imaging-guided laser interstitial thermal therapy for epilepsy: systematic review of technique, indications, and outcomes
10.1093/neuros/nyz556 · doi-reference
Outcome of surgery for hypothalamic hamartoma-related epilepsy
10.1212/wnl.0000000000210060 · doi-reference
MRI-guided laser interstitial thermal therapy in epilepsy: indications, technique and outcome in an adult population. A single-center data analysis
10.1007/s00701-025-06429-3 · doi-reference
Interstitial thermal therapy in mesial temporal lobe epilepsy
10.1001/jamaneurol.2025.1897 · doi-reference
Magnetic resonance–guided laser interstitial thermal therapy for mesial temporal epilepsy: a case series analysis of outcomes and complications at 2-Year Follow-Up
10.1016/j.wneu.2019.03.057 · doi-reference
MR-guided stereotactic laser ablation of epileptogenic foci in children
10.1016/j.yebeh.2012.04.135 · doi-reference
Laser interstitial thermal therapy for intracranial dural-based lesions: a single center case series of 20 patients
10.1016/j.clineuro.2026.109384 · doi-reference
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)
10.1007/s11060-023-04265-y · doi-reference
Reirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery
10.1016/j.ijrobp.2021.10.008 · doi-reference
Repeated in-field radiosurgery for locally recurrent brain metastases: feasibility, results and survival in a heavily treated patient cohort
10.1371/journal.pone.0198692 · doi-reference
